CHEK1 and neoplasm: Thus, it appears that the Chk1 inhibitor, MK-8776 radiosensitizes human tumor cells through an inhibition of NHEJ-mediated repair of radiation-induced DSBs and that occurs preferentially in p53-defective cells and that MK-1775 may have similar effects.